Predicting treatment retention with a brief "opinions about methadone" scale
Predicting treatment retention with a brief "opinions about methadone" scale
复制标题
DOI：
10.1080/02791072.2006.10399832
复制
发表时间：
2006-03-01
影响因子：
2.8
通讯作者：
Rosenblum, A
中科院分区：
文献类型：
--
作者：
Kayman, DJ;Goldstein, MF;Rosenblum, A
确定预测药物滞留的社会条件、项目因素和来访者特征是很重要的，因为药物滥用治疗的时间与健康、情绪和社会功能的改善有关。退出治疗的患者也面临严重危害的高风险，包括复发。大多数阿片类药物依赖者需要长期稳定的美沙酮维持治疗（MMT）以使脑功能正常化并控制戒断症状。本研究的目的是确定病人的特征，即对美沙酮的态度，是否与保留有关。对14份关于美沙酮的意见陈述进行分析，确定了一个可靠的五项量表，具有析因效度。该量表（关于美沙酮的意见：OAM-5）也预测了MMT的保留率。在加入MMT一年后，338名患者接受了随访，48%的患者退出了治疗；那些更有可能留下来的人有更有利的看法。一项针对MMT咨询师的补充性质的研究证实了OAM-5的面效度；咨询师发现这些项目易于解释，并且与来访者对MMT的态度有关。研究结果表明，MMT工作人员在入院时使用OAM-5评估来访者的态度是值得的。这将有助于他们识别并及时干预那些最需要支持继续治疗的人。
It is important to identify social conditions, program factors, and client characteristics that predict retention because time in substance abuse treatment is associated with improved health, mood, and social functioning. Treatment dropouts also are at high risk for serious harms, including relapse. Most opioid-dependent persons require long-term stabilization in methadone maintenance treatment (MMT) to normalize brain function and control withdrawal symptoms. The purpose of this study was to determine whether a client characteristic, namely, attitude toward methadone, was related to retention. Analysis of 14 opinion statements about methadone identified a reliable five-item scale with factorial validity. This scale (Opinions About Methadone: OAM-5) also predicted retention in MMT Of 338 clients followed for one year after MMT enrollment, 48% dropped out of treatment; those who were more likely to remain had more favorable opinions. A supplementary qualitative study with MMT counselors demonstrated face validity for the OAM-5; counselors found the items easy to interpret and relevant to client attitudes towards MMT. The findings suggest that it would be worthwhile for MMT staff to assess client attitudes at intake, using the OAM-5. This would help them to identify and intervene promptly with those in greatest need of support for remaining in treatment.